Overview

A Study of Insulin Glargine (LY2963016) in Adult Participants With Type 2 Diabetes in India

Status:
Completed
Trial end date:
2021-07-30
Target enrollment:
Participant gender:
Summary
The reason for this study is to see if insulin glargine is safe in participants with type 2 diabetes mellitus (T2DM) in India.
Phase:
Phase 4
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Insulin
Insulin Glargine
Insulin, Globin Zinc